FDA Import Refusal SCS-1313698-8/20002/1 — Novo Nordisk A/S

Novo Nordisk A/S — FEI 3000151819

The FDA refused shipment SCS-1313698-8/20002/1 from Novo Nordisk A/S (Denmark) on May 12, 2026. The refused product falls under Drugs and Biologics — SEMAGLUTIDE (ANTI-DIABETIC). Cited charges: 9999982,9999983 This firm has 5 or more other import refusals on record.